The contraceptives market in Germany, specifically those based on hormones or spermicides, is seeing a steady decline in value per capita from $5.59 in 2024 to $5.28 by 2028. This trend reflects a consistent year-on-year decrease of approximately 1.5%, with a cumulative average growth rate (CAGR) over the forecasted period also showing a negative trend.
Future trends to watch for include the impact of policy changes on contraceptive accessibility and potential shifts in consumer preferences towards non-hormonal or alternative contraceptive methods, which could further influence market dynamics.
